376253666	376253666	CD	B-NP	O
|	|	NN	I-NP	O
PH	PH	NN	I-NP	O
|	|	NN	I-NP	O
22342880	22342880	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3715788	3715788	CD	B-NP	O
|	|	CC	I-NP	O
10/14/2004	10/14/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
2/2	2/2	CD	I-NP	I-protein
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/14/2004	10/14/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/23/2004	6/23/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
RHETT	RHETT	NNP	B-NP	O
,	,	,	O	O
MCKINLEY	MCKINLEY	NNP	B-NP	O
R.	R.	NNP	I-NP	O
706-37-09-2	706-37-09-2	CD	I-NP	O
Arvwarklumt	Arvwarklumt	NNP	I-NP	O
Que	Que	NNP	I-NP	O
Na	Na	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/16/04	10/16/04	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JUSTASON	JUSTASON	NNP	B-NP	O
,	,	,	O	O
SOLOMON	SOLOMON	NNP	B-NP	O
TIMOTHY	TIMOTHY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	B-protein
INHALER	INHALER	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
ELAVIL	ELAVIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMITRIPTYLINE	AMITRIPTYLINE	NNP	I-NP	O
HCL	HCL	NN	I-NP	B-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
25	25	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
ECASA	ECASA	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
ASPIRIN	ASPIRIN	NNP	I-NP	I-DNA
ENTERIC	ENTERIC	NNP	I-NP	I-DNA
COATED	COATED	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
325	325	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
ATENOLOL	ATENOLOL	NNP	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
2/14	2/14	CD	I-NP	I-DNA
-RRB-	-RRB-	HYPH	I-NP	O
BUSPAR	BUSPAR	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
BUSPIRONE	BUSPIRONE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NNP	B-NP	I-protein
15	15	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LASIX	LASIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
-RRB-	-RRB-	NNP	B-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/14	2/14	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Or	Or	CC	O	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
by	by	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
providers	provider	NNS	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/8/04	11/8/04	CD	B-NP	O
by	by	IN	B-PP	O
TRUSTY	TRUSTY	NNP	B-NP	O
,	,	,	O	O
JAMEY	JAMEY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
NTG	NTG	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	:	O	I-protein
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	I-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
X	X	NN	I-NP	O
3	3	CD	I-NP	O
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	B-protein
Chest	Chest	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
DARVON-N	DARVON-N	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
PROPOXYPHENE	PROPOXYPHENE	NNP	I-NP	I-protein
NAPSYLATE	NAPSYLATE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q8H	Q8H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
Pain	Pain	NN	I-NP	I-protein
TRAZODONE	TRAZODONE	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
HS	HS	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
2/14	2/14	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Insomnia	Insomnia	NNP	I-NP	I-protein
GLARGINE	GLARGINE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
70	70	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
PROTONIX	PROTONIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FOSAMAX	FOSAMAX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ALENDRONATE	ALENDRONATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
70	70	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Take	Take	NN	I-NP	O
with	with	IN	B-PP	O
8	8	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
plain	plain	JJ	B-NP	B-protein
water	water	NN	I-NP	I-protein
ZOLOFT	ZOLOFT	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
SERTRALINE	SERTRALINE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
125	125	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
2/14	2/14	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
LIPITOR	LIPITOR	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/14	2/14	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
note	note	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
is	be	VBZ	B-VP	O
TEN	TEN	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
10	10	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	B-NP	O
not	not	RB	I-NP	O
80	80	CD	B-NP	O
MG	MG	NN	I-NP	O
as	as	IN	B-SBAR	O
written	write	VBN	B-VP	O
above	above	RB	B-ADVP	O
per	per	IN	B-PP	O
computer	computer	NN	B-NP	O
default	default	NN	I-NP	O
AMBIEN	AMBIEN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ZOLPIDEM	ZOLPIDEM	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Insomnia	Insomnia	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Shortness	Shortness	NNP	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
PREDNISONE	PREDNISONE	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
AS	AS	NNP	B-NP	O
DIRECTED	DIRECTED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
YOUR	YOUR	NNP	I-NP	O
RHEUMATOLOGIST	RHEUMATOLOGIST	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Jim	Jim	NNP	I-NP	O
Laurito	Laurito	NNP	I-NP	O
,	,	,	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
,	,	,	O	O
234-865-1925	234-865-1925	CD	B-NP	O
4/5	4/5	CD	I-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Max	Max	NNP	I-NP	O
Defenderfer	Defenderfer	NNP	I-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	O
11/10	11/10	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Lucius	Lucius	NNP	I-NP	O
Brace	Brace	NNP	I-NP	O
,	,	,	O	O
Psychiatry	Psychiatry	NNP	B-NP	O
,	,	,	O	O
611-691-8394	611-691-8394	CD	B-NP	O
1/11/04	1/11/04	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Randy	Randy	NNP	B-NP	O
Riese	Riese	NNP	I-NP	O
,	,	,	O	O
Heart	Heart	NNP	B-NP	O
Failure	Failure	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
At	At	NNP	I-NP	O
Mah	Mah	NNP	I-NP	O
.	.	.	O	O

Memorial	Memorial	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
UT	UT	NNP	B-NP	O
,	,	,	O	O
Virno	Virno	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/19/04	10/19/04	CD	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
PERCOCET	PERCOCET	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
2/2	2/2	CD	I-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
2/2	2/2	CD	I-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
h/o	h/o	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
;	;	:	O	O
arthritis	arthritis	NN	B-NP	O
;	;	:	O	O
DM	DM	NN	B-NP	O
Type	Type	NN	I-NP	O
II	II	CD	I-NP	O
;	;	:	O	O
asthma	asthma	NN	B-NP	O
;	;	:	O	O
obesity	obesity	NN	B-NP	O
;	;	:	O	O
depression	depression	NN	B-NP	O
;	;	:	O	O
ra	ra	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
rheumatoid	rheumatoid	JJ	I-NP	I-protein
arthritis	arthritis	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
;	;	:	O	O
fibromyalgia	fibromyalgia	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
pud	pud	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
peptic	peptic	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
62	62	CD	B-NP	O
F	F	NN	I-NP	O
admitted	admit	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
h/o	h/o	NN	I-NP	O
increasing	increase	VBG	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
&	&	CC	I-NP	O
chest/neck	chest/neck	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
RCA	RCA	NN	I-NP	O
PTCA/stent	PTCA/stent	NN	I-NP	O
3/17	3/17	CD	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
repeat	repeat	NN	B-NP	O
cath	cath	NN	I-NP	O
9/27	9/27	CD	I-NP	O
patent	patent	NN	I-NP	O
w/o	w/o	NN	I-NP	O
significant	significant	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
CAF	CAF	NN	I-NP	O
;	;	:	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
;	;	:	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
;	;	:	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
presumed	presume	VBD	B-VP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
2/19	2/19	CD	B-NP	O
TTE	TTE	NN	I-NP	O
showing	show	VBG	B-VP	O
LVEF	LVEF	NN	B-NP	B-protein
=	=	SYM	B-VP	O
65-70	65-70	CD	B-NP	O
%	%	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
mild	mild	JJ	I-NP	O
cLVH	cLVH	NN	I-NP	O
;	;	:	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
recently	recently	RB	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
low-dose	low-dose	JJ	B-NP	O
prednisone	prednisone	NN	I-NP	O
5	5	CD	I-NP	O
qd	qd	NN	I-NP	O
;	;	:	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
asthma	asthma	NN	I-NP	O
per	per	IN	B-PP	O
pt	pt	NN	B-NP	O
;	;	:	O	O
7	7	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
;	;	:	O	O
8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
fibromyalgia	fibromyalgia	NNS	I-NP	O
;	;	:	O	O
9	9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
;	;	:	O	O
10	10	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
gastritis/DU	gastritis/DU	NN	I-NP	O
;	;	:	O	O
11	11	CD	B-NP	O
-RRB-	-RRB-	:	O	O
s/p	s/p	NN	B-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
described	describe	VBD	B-VP	O
subacute	subacute	JJ	B-NP	O
chest/neck	chest/neck	NN	I-NP	O
diffuse	diffuse	JJ	I-NP	O
discomfort	discomfort	NN	I-NP	O
and	and	CC	O	O
episodic	episodic	JJ	B-NP	B-protein
SOB	SOB	NN	I-NP	I-protein
possibly	possibly	RB	B-NP	O
worse	worse	JJR	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
exertion	exertion	NN	I-NP	O
though	though	IN	B-SBAR	O
not	not	RB	O	O
clearly	clearly	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
activity	activity	NN	B-NP	O
,	,	,	I-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	I-NP	O
meals	meal	NNS	I-NP	O
,	,	,	I-NP	O
position	position	NN	I-NP	O
,	,	,	I-NP	O
nitro	nitro	NN	I-NP	O
and	and	CC	I-NP	O
w/o	w/o	NN	I-NP	O
further	further	RB	B-NP	O
associated	associate	VBN	I-NP	O
sxs	sx	NNS	I-NP	O
.	.	.	O	O

Notes	Note	NNS	B-NP	O
medication	medication	NN	I-NP	O
non-adherence	non-adherence	JJ	B-ADJP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
depression	depression	NN	B-NP	O
and	and	CC	O	O
not	not	RB	O	O
re-filling	re-filling	JJ	B-NP	O
meds	med	NNS	I-NP	O
;	;	:	O	O
includes	include	VBZ	B-VP	O
no	no	DT	B-NP	O
lasix	lasix	NN	I-NP	B-protein
x3	x3	NN	I-NP	I-protein
+	+	SYM	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Seen	Seen	NN	B-NP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
SaO2	SaO2	NN	I-NP	O
noted	note	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
91	91	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
on	on	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
prior	prior	RB	B-ADVP	O
but	but	CC	I-ADVP	O
not	not	RB	I-ADVP	O
currently	currently	RB	B-ADVP	O
for	for	IN	B-PP	O
e/o	e/o	NN	B-NP	B-protein
PNA	PNA	NN	I-NP	I-protein
-RRB-	-RRB-	SYM	O	I-protein
-	-	HYPH	O	O
>	>	SYM	B-NP	O
admitted	admit	VBN	B-VP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
evaluated	evaluate	VBN	B-VP	O
for	for	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
neck/chest	neck/chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
&	&	CC	I-NP	O
hyoxemia	hyoxemia	NN	I-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

Performed	Performed	NNP	B-NP	O
ABG	ABG	NNP	I-NP	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
hypoxemia	hypoxemia	NN	B-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
3L	3L	NN	B-NP	B-DNA
NC	NC	NN	I-NP	I-DNA
7.45	7.45	CD	I-NP	I-DNA
/	/	SYM	I-NP	I-DNA
45/79	45/79	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	I-NP	O
Aa	Aa	NNP	I-NP	O
gradient	gradient	NN	I-NP	O
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
158	158	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Suspected	Suspect	VBN	I-NP	O
DIASTOLIC	DIASTOLIC	NN	I-NP	O
DYSFUNCTION	DYSFUNCTION	NN	I-NP	O
in	in	IN	B-PP	O
context	context	NN	B-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
heart	heart	NN	I-NP	O
dz/HTN	dz/HTN	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
med	me	VBN	B-NP	O
compliance	compliance	NN	I-NP	O
including	include	VBG	B-PP	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
supported	support	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
mild	mild	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
diuresis	diuresis	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
lasix	lasix	CD	I-NP	O
40	40	CD	I-NP	O
IV	IV	CD	I-NP	O
qd	qd	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
resting	rest	VBG	B-NP	O
&	&	CC	I-NP	O
ambulatory	ambulatory	JJ	I-NP	O
SaO2s	SaO2	NNS	I-NP	O
>	>	SYM	B-NP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
and	and	CC	O	O
resting	rest	VBG	B-NP	O
SaO2	SaO2	NN	I-NP	O
>	>	JJR	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
though	though	IN	B-SBAR	O
decreased	decrease	VBN	B-VP	O
to	to	TO	B-PP	O
87	87	CD	B-NP	O
%	%	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
ambulation	ambulation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
;	;	:	O	O
b	b	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
underlying	underlie	VBG	B-VP	O
CAD/HTN	CAD/HTN	NN	B-NP	B-protein
;	;	:	O	O
c	c	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
repeat	repeat	NN	I-NP	O
TTE	TTE	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
low	low	JJ	I-NP	O
E/A	E/A	NN	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dyfxn	dyfxn	NN	I-NP	O
;	;	:	O	O
d	d	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
crackles	crackle	NNS	I-NP	O
though	though	IN	B-SBAR	O
no	no	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
JVD	JVD	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-NP	O
admission	admission	NN	I-NP	O
BNP	BNP	NN	I-NP	O
=	=	SYM	B-VP	O
102	102	CD	B-NP	O
&	&	CC	I-NP	O
still	still	RB	I-NP	O
some	some	DT	B-NP	O
hypoxemia	hypoxemia	NN	I-NP	O
at	at	IN	B-PP	O
DC	DC	NN	B-NP	B-cell_type
&	&	CC	I-NP	O
unclear	unclear	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
despite	despite	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
suggesting	suggest	VBG	B-VP	O
additional	additional	JJ	B-NP	O
process	process	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
PFTs	PFT	NNS	I-NP	B-protein
suggest	suggest	VBP	B-VP	O
RVD	RVD	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
?	?	.	O	O

obesity/CHF	obesity/CHF	NN	B-NP	O
v	v	NN	I-NP	O
other	other	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
;	;	:	O	O
A-mibi	A-mibi	NNP	B-NP	O
w/o	w/o	AFX	O	O
e/o	e/o	AFX	O	O
active	active	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
;	;	:	O	O
CXR/CT	CXR/CT	NN	B-NP	O
not	not	RB	B-ADJP	O
suggestive	suggestive	JJ	I-ADJP	O
of	of	IN	B-PP	O
interstitial	interstitial	JJ	B-NP	O
abnormality/thromboembolic	abnormality/thromboembolic	JJ	I-NP	O
dz/PNA	dz/PNA	NN	I-NP	O
;	;	:	O	O
episode	episode	NN	B-NP	O
of	of	IN	B-PP	O
panic	panic	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
more	more	JJR	B-NP	O
dypnea	dypnea	NN	I-NP	O
possibly	possibly	RB	B-VP	O
further	further	RB	I-VP	O
explaining	explain	VBG	I-VP	O
SOB	SOB	NN	B-NP	B-protein
though	though	IN	B-SBAR	O
not	not	RB	B-NP	O
hypoxemia	hypoxemia	NN	I-NP	O
.	.	.	O	O

Outpt	Outpt	JJ	B-NP	O
consideration	consideration	NN	I-NP	O
of	of	IN	B-PP	O
full	full	JJ	B-NP	O
PFTS	PFTS	NNS	I-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	O
screen	screen	NN	I-NP	O
,	,	,	O	O
screen	screen	NN	B-NP	O
for	for	IN	B-PP	O
shunt	shunt	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	I-protein
not	not	RB	O	I-protein
pursued	pursued	JJ	B-NP	I-protein
given	give	VBN	I-NP	I-protein
correction	correction	NN	I-NP	I-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	I-protein
supplemental	supplemental	JJ	I-NP	I-protein
O2	O2	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
pt	pt	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	O	O
a	a	DT	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
pulm	pulm	NN	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
if	if	IN	B-SBAR	O
possible	possible	JJ	B-NP	O
ILD/other	ILD/other	NN	I-NP	O
despite	despite	IN	B-PP	O
nl	nl	NN	B-NP	B-protein
CT	CT	NN	I-NP	I-protein
given	give	VBN	B-VP	I-protein
RVD/hypoxia/RA	RVD/hypoxia/RA	NN	B-NP	I-protein
&	&	CC	O	I-protein
consider	consider	VB	B-VP	O
full	full	JJ	B-NP	O
PFTs	PFT	NNS	I-NP	O
including	include	VBG	B-PP	O
lung	lung	NN	B-NP	O
volumes	volume	NNS	I-NP	O
&	&	CC	O	O
consider	consider	VB	B-VP	O
contribution	contribution	NN	B-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
OSA/hypoventilation	OSA/hypoventilation	NN	I-NP	O
;	;	:	O	O
b	b	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
clinic	clinic	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
discharge	discharge	NN	I-NP	O
weight	weight	NN	I-NP	O
=	=	SYM	B-VP	O
186.4	186.4	CD	B-NP	O
though	though	IN	B-SBAR	O
no	no	DT	B-NP	O
relaible	relaible	JJ	I-NP	B-protein
weights	weight	NNS	I-NP	I-protein
established	establish	VBN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
;	;	:	O	O
c	c	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PCP	PCP	NN	I-NP	O
;	;	:	O	O
d	d	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
psychiatry	psychiatry	NN	I-NP	O
to	to	TO	B-VP	O
enhance	enhance	VB	I-VP	O
mood	mood	NN	B-NP	O
and	and	CC	I-NP	O
med	med	JJ	I-NP	O
adherence	adherence	NN	I-NP	O
.	.	.	O	O

Established	Establish	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
transiently	transiently	RB	B-ADVP	O
at	at	IN	B-PP	O
2L	2L	NN	B-NP	O
given	give	VBN	B-VP	O
borderline	borderline	JJ	B-NP	O
hypoxemia	hypoxemia	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
ambulation	ambulation	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
and	and	CC	O	O
much	much	RB	B-NP	O
improved	improve	VBN	I-NP	O
sxs	sx	NNS	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
note	note	NN	I-NP	O
that	that	IN	B-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
intended	intend	VBN	I-VP	O
to	to	TO	I-VP	O
make	make	VB	I-VP	O
NO	NO	NN	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
case	case	NN	O	O
you	you	PRP	B-NP	O
note	note	VBP	B-VP	O
any	any	DT	B-NP	O
discrepanices	discrepanice	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
exception	exception	NN	I-NP	O
:	:	:	O	O
we	we	PRP	B-NP	O
increased	increase	VBD	B-VP	O
lisiniopril	lisiniopril	NN	B-NP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
critical	critical	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
take	take	VBP	B-VP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
lasix	lasix	CD	I-NP	O
-	-	HYPH	I-NP	O
seek	seek	JJ	I-NP	O
help	help	NN	I-NP	O
from	from	IN	B-PP	O
your	your	PRP$	B-NP	O
pharmacists/primary	pharmacists/primary	JJ	I-NP	O
providers	provider	NNS	I-NP	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-VP	O
as	as	IN	B-PP	O
arrangements	arrangement	NNS	B-NP	O
including	include	VBG	B-PP	O
pill	pill	NN	B-NP	O
packs	pack	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
critical	critical	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
see	see	VBP	B-VP	O
your	your	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
providers	provider	NNS	I-NP	O
as	as	IN	B-SBAR	O
outlined	outline	VBN	B-VP	O
for	for	IN	B-PP	O
continued	continued	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
though	though	IN	B-SBAR	O
seek	seek	JJ	B-NP	O
medical	medical	JJ	I-NP	O
attention	attention	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
anything	anything	NN	B-NP	O
of	of	IN	B-PP	O
concern	concern	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Consider	Consider	VB	B-VP	O
full	full	JJ	B-NP	O
PFTS	PFTS	NNS	I-NP	O
,	,	,	O	O
screen	screen	NN	B-NP	O
for	for	IN	B-PP	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
adjustment	adjustment	NN	B-NP	O
of	of	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
TTE	TTE	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
bubble	bubble	NN	I-NP	O
if	if	IN	B-SBAR	O
no	no	DT	B-NP	O
improvement	improvement	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DENNIES	DENNIES	NNP	B-NP	O
,	,	,	O	O
KELLY	KELLY	NNP	B-NP	O
E.	E.	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DN10	DN10	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/16/04	10/16/04	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

